Rohrbaugh Named Director of OTT
Dr. Mark L. Rohrbaugh has been named director of the Office of Technology Transfer in the Office of Intramural Research, OD. He will oversee the patenting and licensing of NIH inventions and contribute to intramural and extramural technology transfer policy at NIH and HHS.
During the past 10 years, NIH executed more than 1,800 licenses to inventions made by its intramural research program resulting in more than $350 million in royalties. More importantly, these efforts have resulted in the development, by its commercial partners, of more than 20 life-saving drugs, vaccines and diagnostics and more than 100 other biomedical products.
Rohrbaugh started his career at NIH in 1991 as scientific review administrator for the allergy, immunology, and transplantation research committee, NIAID. In 1995, he moved from NIAID's extramural program to the institute's Office of Technology Development, serving as director of that office from 1997 to 2001. Before joining NIH, Rohrbaugh conducted molecular and cell biology research as a McKnight Foundation postdoctoral fellow at the University of Minnesota and as a research and senior scientist at two biotechnology companies in Minneapolis.
Up to Top